The visceral sensitivity index: A novel tool for measuring GI-symptom-specific anxiety in inflammatory bowel disease.
Kimberly TrieschmannLin ChangSarah ParkBruce D NaliboffSwapna JoshiJennifer S LabusJenny S SaukBerkeley N LimketkaiEmeran A MayerPublished in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2022)
Our findings suggest the VSI is a useful measure in IBD. The VSI in IBD is related to general anxiety but is measuring a different construct and is not affected by the presence of trait anxiety. IBD patients have GSA that is associated with decreased HRQOL, which can negatively affect treatment compliance and other long-term disease outcomes. Future studies are needed to further validate the VSI in IBD and to assess its correlation with disease activity.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- end stage renal disease
- sleep quality
- ulcerative colitis
- rheumatoid arthritis patients
- ejection fraction
- chronic kidney disease
- ankylosing spondylitis
- peritoneal dialysis
- prognostic factors
- type diabetes
- insulin resistance
- genome wide
- gene expression
- skeletal muscle
- weight loss